Physician profile
Jason Lam
NPI 1770346371
$4,026.77
in general payments reported to CMS, 2019-2025
16 companies · $2,821 in 2025
The $2,821 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,206 · 2025: $2,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,026.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $804.66 | 2024-2025 | Dupixent |
| Genzyme Corporation | $706.54 | 2024-2025 | |
| Amgen INC. | $556.11 | 2024-2025 | Otezla, Otezla |
| Abbvie INC. | $417.41 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $300.64 | 2024-2025 | |
| Incyte Corporation | $246.90 | 2024-2025 | Opzelura, Opzelura |
| Lilly USA, LLC | $233.79 | 2024-2025 | Olumiant, Ebglyss, Taltz |
| Arcutis Biotherapeutics, INC. | $197.71 | 2025 | Zoryve |
| Galderma Laboratories, L.P. | $145.08 | 2024-2025 | Nemluvio |
| Sun Pharmaceutical Industries INC. | $120.85 | 2025 | |
| Pfizer INC. | $106.05 | 2024 | |
| Dermavant Sciences, INC. | $105.14 | 2024 | Vtama |
| Lnhc, INC | $25.00 | 2025 | Zelsuvmi |
| Ani Pharmaceuticals, INC. | $21.04 | 2025 | Purified Cortrophin Gel |
| Organogenesis INC. | $20.81 | 2025 | Cygnus Dual |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $19.04 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.